DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”), is pleased to announce that it has closed a transaction with 1884356 Alberta Ltd. (the “Vendor”) to acquire all or substantially all of the Vendor’s assets relating to the operation of two retail cannabis stores in Edmonton, Alberta (the “Transaction”). The acquisition was completed through the Company’s wholly-owned subsidiary, Delta 9 Cannabis Store Inc. pursuant to an asset purchase agreement between Delta 9 Cannabis Store Inc. and the Vendor dated July 9, 2021.

After more than two years of underperforming the markets, investors will be hoping for Canadian cannabis stocks to gain momentum by the end of 2021. A majority of marijuana players in Canada were hit by a slew of structural issues as well as the ongoing pandemic in addition to constant equity capital raises that diluted shareholder wealth significantly.

Several cannabis producers are looking to narrow their losses by focusing on supply chain improvements as well as selling high-margin products. Here, we compare HEXO (TSX:HEXO)(NYSE:HEXO) and Sundial (NASDAQ:SNDL) to see which is a better stock to buy right now.

When the World Health Organization declared COVID 19 virus a global pandemic, hundreds of businesses and markets worldwide fell apart. A majority of them enacted temporary closures. Others reduced operations, which meant relieving off some employees their duties. Finally, however, things have begun to show up if some businesses’ Q2 2021 Financial results are anything to go by. Take, for example, Village Farms International Inc (NASDAQ: VFF) 

2 Top Canadian Marijuana Stocks To Add To Your September Watchlist

A good amount of marijuana stocks are still dealing with the up and down trading that’s taking place. Now even with some cannabis stocks showing good entry levels investors want to see a bigger rise in the sector. From November 2020 through the first month and a half of 2021, many cannabis stocks were able to see a consistent climb in trading.

With cannabis still being illegal on the federal level — classified as a Schedule 1 controlled substance with “no currently accepted medical use” — companies in the sector find it difficult, if not impossible, to list on major U.S. stock exchanges like the New York Stock Exchange (NYSE) and NASDAQ.

Neither of these stock exchanges accepts companies that sell cannabis in the U.S., even when operating in states where adult-use consumption is now legal. That’s because federal law trumps state law. And, with the feds and the state not being in sync on this important issue, confusion and controversy pop up on a regular basis. Is medical marijuana legal in nursing homes and assisted living facilities? Can sports leagues allow athletes to medicate with cannabis? What about the V.A.?

The improvement in adjusted EBITDA can be attributed to Indiva reporting strong revenue growth. The better sales numbers were negatively impacted by higher operating expenses and we are not surprised by this increase. We are favorable on how the business has advanced and believe the business is well positioned to capitalize on a burgeoning vertical of the Canadian cannabis industry. 

A key aspect of the Indiva story is related to the relationship it has with leading US cannabis brands like Wana Sour Gummies and Bhang Chocolate. Going forward, we expect these brands to serve as a key growth driver for the business and are favorable on how sales numbers have been ramping up. 

Developed countries are falling over each other to legalise marijuana and its sister – industrial hemp. Kenya has a Bill laying eggs in Parliament over legalising the same. While marijuana and hemp are from the same cannabis family, they’re different: weed is a recreational, intoxicating substance, hemp, on the other end of the joint, is a sub-species of the cannabis plant with benefits of industrial proportions. 

Marijuana is used for recreation as it has a higher level of tetrahydrocannabinol, the psychoactive compound which leaves smokers feeling like touching the sky. Hemp has lower levels of tetrahydrocannabinol and thus not ideal for altering a person’s mental state via intoxication. 

As Canada's cannabis market reaches another level of maturity, industry consultancy Brightfield Group sees a significant shift in how Canadian consumers engage with the product. Product usage and demographic profiles have shifted considerably since Canada legalized cannabis, offering producers and retailers alike a different perspective in what items could be a success or what could be deemed a failure. Here's a look at four trends observed by Brightfield in the Canadian market following a quarterly survey of 3,000 adult cannabis users released by the consultancy on Friday:

Among the growth sectors investors have largely lost focus on of late is cannabis. Indeed, the amount of discussion around companies like Canopy Growth (TSX:WEED)(NYSE:CGC) stock has dwindled of late. With meme stocks soaring, and so many other opportunities for outlandish growth present in today’s market, this makes sense.

However, one could argue that cannabis stocks were the original meme stocks. These companies garnered a tremendous amount of attention in previous years. Indeed, as Canada legalized recreational cannabis use, the expectation was that a Biden government would follow.

However, we haven’t seen anything concrete play out yet south of the border. Accordingly, investor interest has seemingly shifted to other high-growth sectors today.